Cure My Disease

Don't miss your cure!

 Log in / Sign up

Step by step: a coaching program aims to keep heart patients moving after rehab

NCT ID NCT07723274

Not yet recruiting Disease control Sponsor: Radboud University Medical Center Source: ClinicalTrials.gov ↗

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This trial tests whether a 9-month program called STEP COACH can help people with coronary artery disease stay physically active after completing cardiac rehab. Participants use their own smartwatch or smartphone to track steps and receive coaching on increasing both step volume and intensity. The study compares changes in daily moderate-to-vigorous physical activity between those who receive the program and those who get usual care alone.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a 9-month behavioral coaching program called STEP COACH that uses step targets and smartwatch tracking to encourage physical activity
What this could lead to
If it works, this program could help heart patients maintain higher physical activity levels after cardiac rehab, potentially reducing their risk of future heart problems.
What could go wrong
This is a relatively small trial, and the effect may be modest. Participants need to stay motivated for 9 months, and results may not apply to all heart patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder coronary artery disorder Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY ARTERY DISEASE

Contacts and locations

Locations

  • Bernhoven

    Uden, 5406PT, Netherlands

  • Canisius Wilhelmina Ziekenhuis

    Nijmegen, 6532SZ, Netherlands

  • Radboud university medical center

    Nijmegen, 6525GA, Netherlands

  • Rijnstate

    Arnhem, 6815AD, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.